Mazabraud’s syndrome and thyroid cancer, a very rare and confusing association: a case report

BMC Endocrine Disorders

Bogdan Fetica²  Andra Piciu¹  Elena Barbus³  Doina Piciu³ 

[1] Department of Oncology, Institute of Oncology “Prof. Dr. Ion Chiricuta” 34–36 Republicii, Cluj-Napoca, 400015, Romania;Department of Pathology, Institute of Oncology “Prof. Dr. Ion Chiricuta” 34–36 Republicii, Cluj-Napoca, 400015, Romania;University of Medicine and Pharmacy “Iuliu Hatieganu” 6–8 V. Babes, Cluj-Napoca, 400012, Romania

关键词: Thyroid cancer;    Myxoma;    Bone dysplasia;    Mazabraud’s syndrome;   

Others  :  1222361
DOI  :  10.1186/s12902-015-0036-z

 received in 2015-02-22, accepted in 2015-07-24,  发布年份 2015

【 摘 要 】

Background

Mazabraud’s syndrome is defined as the association between fibrous dysplasia and intramuscular myxomas. The syndrome was first described in 1967 and, up until now, less than 100 cases have been reported worldwide. Here we report the association between this rare syndrome and thyroid cancer. When a malignant disease occurs in a patient affected by this syndrome, the differential diagnosis between benign and malignant bone lesions should be undertaken carefully.

Case presentation

We report the case of a 57-year-old Caucasian male, admitted for diffuse bone pain localized in the left leg and for the presence of an indolent, slow-growing mass in the left shoulder. The patient also presented with a thyroid nodule, highly suggestive of a malignancy. The radiologic examination showed multiple osteolytic lesions. The suspicion of multiple myeloma or bone metastases arising from a thyroid cancer was considered. Electrophoresis of proteins was negative and therefore excluded the diagnosis of multiple myeloma; the thyroid surgery was indicated. Thyroidectomy confirmed the papillary thyroid carcinoma, and the bone lesions were considered to be metastases from the thyroid cancer. After surgery, under thyroid-stimulated hormonal conditions, the patient underwent radioiodine therapy and a post-therapy radioiodine whole body scan. The lack of radioiodine uptake, both in the bone lesions and shoulder mass, suggested the possibility of less differentiated, non-avid radioiodine lesions, or the absence of any relation between pathologies. Considering the low level of the specific tumor marker, thyroglobulin, a bone biopsy and resection of the shoulder mass were indicated. The final diagnosis was intramuscular myxoma with polyostotic fibrous dysplasia in the deltoid muscle (Mazabraud’s syndrome). A completely incidental cerebral tumor lesion was also discovered.

Conclusion

During the evolution of a malignant disease, Mazabraud’s syndrome, known as the association of intramuscular myxoma with fibrous dysplasia, should be considered in the differential diagnosis of bone metastasis. This is the first report in the literature of Mazabraud’s syndrome occurring in a patient with thyroid cancer.

【 授权许可】

   
2015 Piciu et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Fig. 6.

Fig. 7.

Fig. 8.

Fig. 9.

【 参考文献 】

• [1]Dreizin D, Glen C, Jose J. Mazabraud syndrome. Am J Orthop (Belle Mead NJ). 2012; 41:332-5.
• [2]Munksgaard PS, Salkus G, Iyer VV, Fisker RV. Mazabraud’s syndrome: case report and literature review. Acta Radiol Short Reports. 2013;2:2047981613492532.
• [3]Van der Wal WA, Unal H, de Rooy JW, Flucke U, Veth RP. Fibrous dysplasia of bone associated with soft-tissue myxomas as well as an intra-osseous myxoma in a woman with Mazabraud’s syndrome: a case report. J Med Case Rep. 2011; 5:239. BioMed Central Full Text
• [4]Dumitrescu CE, Collins MT. McCune-Albright syndrome. Orphanet J Rare Dis. 2008; 3:12. BioMed Central Full Text
• [5]Prevalence of rare diseases: bibliographic data, 2015, 1: http://www.orpha.net/consor/cgi-bin/Education_Home.php?lng=EN#REPORT_RARE_DISEASES. Accessed 4 Aug 2015.
• [6]Endo M, Kawai A, Kobayashi E, Morimoto Y, Yamaguchi U, Nakatani F, et al. Solitary intramuscular myxoma with monostotic fibrous dysplasia as a rare variant of Mazabraud's syndrome. Skeletal Radiol. 2007;36:523–9.
• [7]Collins MT, Sarlis NJ, Merino MJ, Monroe J, Crawford SE, Krakoff J et al.. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J Clin Endocrinol Metab. 2003; 88:4413-7.
• [8]Zoccali C, Teori G, Prencipe U, Erba F. Mazabraud’s syndrome: a new case and review of the literature. Int Orthop. 2009; 33:605-10.
• [9]Muthusamy S, Subhawong T, Conway SA, Temple HT. Locally aggressive fibrous dysplasia mimicking malignancy: a report of four cases and review of the literature. Clin Orthop Relat Res. 2015; 473:742-50.
• [10]Petscavage-Thomas JM, Walker EA, Logie CI, Clarke LE, Duryea DM, Murphey MD. Soft-tissue myxomatous lesions: review of salient imaging features with pathologic comparison. Radiographics. 2015;34:964–8.